Optimal Treatment for Intermediate- and High-Risk, Nonmuscle-Invasive Bladder Cancer
According to clinical and pathological factors the prognosis of a patient with non-muscle invasive bladder tumors can be assessed. The prognosis is determined by the likelihood of recurrence(30-70%) and/or progression to muscle invasive bladder cancer(1-15%).Trans urethral resection of bladder tum...
Saved in:
Main Author: | A.P.M. van der Meijden |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2006-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2006.403 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Saudi urologists’ treatment pattern for high-risk Bacillus Calmette–Guérin naïve and Bacillus Calmette–Guérin unresponsive nonmuscle invasive bladder cancer
by: Mohammad Alghafees, et al.
Published: (2025-01-01) -
The Clinical Impact of Tumor Grade Heterogeneity in Nonmuscle- invasive Urothelial Carcinoma of the Bladder
by: Meftun Culpan, et al.
Published: (2021-12-01) -
Routine Surveillance of Upper Urinary Tract Imaging for Diagnosing Upper Urinary Tract Urothelial Cancer Recurrence in Patients with Nonmuscle Invasive Bladder Cancer
by: Nobutaka Nishimura, et al.
Published: (2024-01-01) -
Trimodal organ‑preserving treatment of muscle‑invasive bladder cancer
by: A. V. Troianov, et al.
Published: (2023-03-01) -
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
by: Liam Mannion, et al.
Published: (2024-11-01)